Tag: Emergent Technologies Inc
Pure Protein LLC Appoints Dr. Rico Buchli as Chief Scientist
eNewsChannels NEWS: -- Pure Protein L.L.C. proudly announces the appointment of Dr. Rico Buchli as Chief Scientist. In his new role, Dr. Buchli will lead scientific initiatives and oversee the expansion of the company's immunological products and services portfolio. This strategic move underscores Pure Protein's commitment to providing innovative, high-quality reagents to the global research and diagnostics community.
Pure MHC LLC and Myrio Announce Collaboration to Research and Develop Targeted Antibody-Based Cancer Therapies
eNewsChannels NEWS: -- Pure MHC, LLC and Myrio Therapeutics Pty Ltd (Myrio) today announced a collaboration to develop new antibody-based oncology therapeutics. The companies will combine Pure MHC's proprietary offering of MHC peptide targets for oncology with Myrio's revolutionary Retained Display(tm) (ReD) antibody discovery process to initially create up to three novel therapies based on targets distinct to tumors across multiple types of cancer.
Pure MHC Announces Contract Research Service Division and Initial Collaboration Project with argenx
eNewsChannels NEWS: -- Pure MHC, LLC, a target discovery and development company, today announced the launch of its contract research services arm, Pure MHC Solutions, and an initial collaboration project with global immunology company, argenx.
Pure MHC, LLC, today announced the launch of its Peptide HLA Immunotherapy Data Resource
eNewsChannels NEWS: -- Pure MHC, LLC, a target discovery and development company, today announced the launch of its Peptide HLA Immunotherapy Data Resource ("PHIDR"), built through its collaboration with a trusted provider of transplant solutions and a leader in regenerative medicine, LifeNet Health.
New Online Resource from Pure Protein, LLC Offers Its HLA Reagents and Technical Services to Researchers
eNewsChannels NEWS: -- Pure Protein, LLC (Pure Protein) an HLA company that has developed comprehensive analytical capabilities in the field of human leukocyte antigen (HLA) immunology and an approach to produce soluble forms of the HLA molecule (sHLA), is proud to announce the launch of its new website.
Pure Protein, LLC to Exhibit at the American Society for Histocompatibility and Immunogenetics (ASHI) 46th Annual Meeting
eNewsChannels NEWS: -- Pure Protein, LLC (Pure Protein) an HLA company that has developed comprehensive analytical capabilities in the field of human leukocyte antigen (HLA) immunology and an approach to produce soluble forms of the HLA molecule (sHLA), announced today that it will be an exhibitor at the ASHI VIRTUAL ANNUAL MEETING, October 19 - 21, 2020.
